December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Elevated Aquaporin 5 Protein in Tear Fluid of Sjogren's Syndrome
Author Affiliations & Notes
  • Y Ohashi
    Department of Ophthalmology Tokyo Dental College Chiba Japan
  • R Ishida
    Department of Ophthalmology Tokyo Dental College Chiba Japan
  • K Watanabe
    Ophthalmic Research Division Santen Pharmaceutical Co Ltd Nara Japan
  • N Ishida
    Ophthalmic Research Division Santen Pharmaceutical Co Ltd Nara Japan
  • K Nakata
    Ophthalmic Research Division Santen Pharmaceutical Co Ltd Nara Japan
  • LS King
    Division of Pulmonary and Critical Care Medicine and Department of Biological Chemistry Johns Hopkins University School of Medicine Baltimore MD
  • P Agre
    Division of Pulmonary and Critical Care Medicine and Department of Biological Chemistry Johns Hopkins University School of Medicine Baltimore MD
  • T Takeuchi
    The Second Department of Internal Medicine Saitama Medical School Saitama Japan
  • K Tsubota
    Department of Ophthalmology Tokyo Dental College Chiba Japan
  • Footnotes
    Commercial Relationships   Y. Ohashi, None; R. Ishida, None; K. Watanabe, None; N. Ishida, None; K. Nakata, None; L.S. King, None; P. Agre, None; T. Takeuchi, None; K. Tsubota, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 85. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y Ohashi, R Ishida, K Watanabe, N Ishida, K Nakata, LS King, P Agre, T Takeuchi, K Tsubota; Elevated Aquaporin 5 Protein in Tear Fluid of Sjogren's Syndrome . Invest. Ophthalmol. Vis. Sci. 2002;43(13):85.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Aquaporin 5 (AQP5), which is a selective water channel, is highly expressed in lacrimal and salivary glands. The purpose of this study was to evaluate whether the measurement of AQP5 protein content in tear fluid was the optical parameter for Sjogren's Syndrome. Methods: Basal tears were collected from the inferior marginal tear strip of patients with a calibrated capillary tube. The concentration of AQP5 protein was measured by originated human AQP5 ELISA procedure. In this system, human AQP5 was detected by using an affinity-purified antibody to the C-terminus of human AQP5. Results: Quantification of AQP5 protein by ELISA were 38.8 pg/µl in normal controls (n=6), 51.9 pg/µl in non-Sjogren's Syndrome dry eye (n=79), and 116.5 pg/µl in Sjogren's Syndrome patients (n=28). Conclusion: The measurement of AQP5 in tear fluid can be used for diagnosis of Sjogren's Syndrome. These results support the hypothesis that AQP5 protein is leaked into tear fluid when the lacrimal glands are damaged by lymphocytic infiltration in Sjogren's Syndrome.

Keywords: 376 cornea: tears/tear film/dry eye • 324 aqueous • 452 lacrimal gland 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×